AMICUS THERAPEUTICS, INC. (39)

Browse by Contract Category

Contracts

Form of Director and Officer Indemnification Agreement (Filed With SEC on December 28, 2022)
Equity Distribution Agreement, dated November 7, 2022, by and between Amicus Therapeutics, Inc. and Goldman Sachs & Co. LLC (Filed With SEC on November 7, 2022)
Employment Agreement, dated August 1, 2022, by and between the Company and Bradley L. Campbell (Filed With SEC on August 1, 2022)
Amendment #3 to the Amicus Therapeutics, Inc. Cash Deferral Plan (Filed With SEC on November 9, 2021)
Notice of Non-Renewal of Lease Agreement dated August 16, 2011 between the Registrant and Cedar Brook 3 Corporate Center, L.P (Filed With SEC on August 10, 2020)
Fifth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated April 6, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on February 24, 2022)
Third Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 3, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
Fourth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 23, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
Sixth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated August 1, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
Seventh Amendment to the Amended and Restated Research, Collaboration & License Agreement dated September 28, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)
Termination Agreement, dated as of February 23, 2022, by and between ARYA and the Company (Filed With SEC on February 24, 2022)
Employment Agreement, dated February 23, 2022, by and between the Company and John F. Crowley (Filed With SEC on February 24, 2022)
Form of Pre-Funded Warrant (Filed With SEC on September 29, 2021)
Form of Stock Option Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)
Form of Board Stock Option Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)
Form of Board Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)
Second Amendment to the Amended and Restated Research, Collaboration & License Agreement dated (Filed With SEC on May 7, 2020)
First Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 20, 2019 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on May 7, 2020)
Employment Agreement dated February 18, 2020 between the Registrant and Hung Do (Filed With SEC on March 2, 2020)
Employment Agreement dated February 18, 2020, between the Registrant and Daphne Quimi (Filed With SEC on March 2, 2020)
Employment Agreement dated February 18, 2020, between the Registrant and Jay Barth, M.D (Filed With SEC on March 2, 2020)
Employment Agreement dated February 18, 2020, between the Registrant and Bradley L. Campbell (Filed With SEC on March 2, 2020)
Employment Agreement dated February 18, 2020, between the Registrant and Ellen S. Rosenberg (Filed With SEC on March 2, 2020)
Amendment No. 1 to Employment Agreement dated April 23, 2014 between the Registrant and John F. Crowley (Filed With SEC on March 2, 2020)
Description of the Registrant's securities (Filed With SEC on March 2, 2020)
Amendment #2 to the Amicus Therapeutics, Inc. Cash Deferral Plan (Filed With SEC on December 19, 2019)
Amended and Restated Research, Collaboration & License Agreement, dated May 28, 2019, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania (Filed With SEC on August 8, 2019)
Form of Capped Call Transaction Termination Agreement (Filed With SEC on August 8, 2019)
Form of Exchange Agreement Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on June 19, 2019)
Underwriting Agreement, dated May 30, 2019, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and SVB Leerink LLC (Filed With SEC on May 31, 2019)
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on May 22, 2019)
Form of Call Option Partial Termination Agreement (Filed With SEC on May 9, 2019)
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on March 13, 2019)
Separation Agreement with William D. Baird III dated as of February 8, 2019 (Filed With SEC on February 28, 2019)
Research, Collaboration and License Agreement with The Trustees of the University of Pennsylvania dated October 8, 2018 (Filed With SEC on February 28, 2019)
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on February 8, 2019)
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on January 24, 2019)